Alex Schwartz
Stock Analyst at Stifel
(1.80)
# 3,171
Out of 4,905 analysts
11
Total ratings
25%
Success rate
9.19%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Alex Schwartz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANAB AnaptysBio | Initiates: Buy | $50 | $25.92 | +92.90% | 4 | Feb 21, 2024 | |
| VTVT vTv Therapeutics | Downgrades: Hold | n/a | $16.49 | - | 2 | Apr 10, 2018 | |
| GERN Geron | Maintains: Hold | $2.5 → $4 | $1.24 | +222.58% | 1 | Mar 19, 2018 | |
| PBYI Puma Biotechnology | Maintains: Buy | $85 → $95 | $3.40 | +2,694.12% | 4 | Mar 9, 2018 |
AnaptysBio
Feb 21, 2024
Initiates: Buy
Price Target: $50
Current: $25.92
Upside: +92.90%
vTv Therapeutics
Apr 10, 2018
Downgrades: Hold
Price Target: n/a
Current: $16.49
Upside: -
Geron
Mar 19, 2018
Maintains: Hold
Price Target: $2.5 → $4
Current: $1.24
Upside: +222.58%
Puma Biotechnology
Mar 9, 2018
Maintains: Buy
Price Target: $85 → $95
Current: $3.40
Upside: +2,694.12%